ReviewDrug design, development and therapy2025
Comprehensive Treatment of Functional Dyspepsia Using Traditional Chinese Medicine: A Review Based on Pathophysiological Perspectives.
Review in Drug design, development and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Tail-Suspension Model of Simulated Microgravity-Induced Functional Dyspepsia in Rats: Behavioral, Motility, and Brain-Gut Peptide Alterations.International journal of molecular sciences · 2026Article
- Domperidone plus pinaverium bromide and itopride for functional dyspepsia in the elderly: efficacy, symptom improvement, and gastric function panel.American journal of translational research · 2026Article
- From data mining to experimental validation: ST36 and CV12 as core acupoint combination for acupuncture in functional dyspepsia.Frontiers in medicine · 2026Article
- Delivered baicalein immunomodulatory hydrogel with dual properties of pH-responsive and anti-infection orchestrates pro-regenerative response of macrophages for enhanced hypertrophic scars therapy.Materials today. Bio · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Functional dyspepsia (FD) is a common functional gastrointestinal disorder characterized by epigastric pain and symptoms related to meal consumption. According to recent diagnostic criteria, FD can be classified as epigastric pain syndrome (EPS) or postprandial discomfort syndrome (PDS), based on the predominant symptoms. The pathophysiology of FD can be influenced by various factors, including microinflammation, gastrointestinal infections, abnormal gastroduodenal motility, visceral hypersensitivity, disturbances in the brain-gut axis, and psychological factors. As a result, its management requires a comprehensive approach that includes both pharmacological and non-pharmacological interventions such as psychological therapies and adjunctive treatments. However, despite the availability of various treatment options, no contemporary pharmacological agents have been approved specifically for FD. In this context, Traditional Chinese Medicine (TCM) has emerged as a promising alternative that offers notable efficacy and safety in managing FD. Various TCM modalities, including herbal prescriptions, acupuncture, moxibustion, and music therapy have demonstrated therapeutic potential. In this article, we discuss the pathophysiology of FD from a modern medical perspective and describe integrative treatment strategies based on TCM, highlighting the potential benefits of combining the traditional and contemporary approaches.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.